Search

Your search keyword '"Langevin, Jessica"' showing total 29 results
Start Over Author "Langevin, Jessica"
29 results on '"Langevin, Jessica"'

2. Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, primary, Lamarche, Larkin, additional, Freeman, Karla, additional, Ali, Abbas, additional, Clark, Rebecca, additional, Shah, Nikki, additional, Awan, Amen, additional, Langevin, Jessica, additional, Parascandalo, Jenna, additional, Dore Brown, Naomi, additional, Jurcic-Vrataric, Jane, additional, Colwill, Kiska, additional, Dragos, Steven, additional, Borhan, Sayem, additional, Risdon, Cathy, additional, Siu, Henry, additional, Farrell, Barbara, additional, and Trimble, Johanna, additional

Published
2023
Full Text
View/download PDF

3. sj-docx-3-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-3-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

4. sj-docx-2-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-2-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

5. sj-docx-1-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-1-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

8. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, primary, Lamarche, Larkin, additional, Agarwal, Gina, additional, Banh, Hoan Linh, additional, Dore Brown, Naomi, additional, Cassels, Alan, additional, Colwill, Kiska, additional, Dolovich, Lisa, additional, Farrell, Barbara, additional, Garrison, Scott, additional, Gillett, James, additional, Griffith, Lauren E., additional, Holbrook, Anne, additional, Jurcic-Vrataric, Jane, additional, McCormack, James, additional, O’Reilly, Daria, additional, Raina, Parminder, additional, Richardson, Julie, additional, Risdon, Cathy, additional, Savelli, Mat, additional, Sherifali, Diana, additional, Siu, Henry, additional, Tarride, Jean-Éric, additional, Trimble, Johanna, additional, Ali, Abbas, additional, Freeman, Karla, additional, Langevin, Jessica, additional, Parascandalo, Jenna, additional, Templeton, Jeffrey A., additional, Dragos, Steven, additional, Borhan, Sayem, additional, and Thabane, Lehana, additional

Published
2021
Full Text
View/download PDF

15. Pathways to Post-secondary Education: Engaging Families of Students in Grades 6-8

Author

de Bie, Alise, Bergey, Ben, Cosme, Renee, Langevin, Jessica, Leanage, Allison, Kim, Sol Ji, and None

Subjects
middle school children, parent engagement, pathways to post-secondary education, information and communication technologies
Abstract

This report has been prepared by Research Associates from the McMaster Research Shop at the request of the Industry Education Council (IEC). It is intended to review best practices for engaging parents of children in Grades 6-8 in conversations about pathways to postsecondary and career opportunities for their kids.

Published
2016

16. Primary care clinicians' confidence, willingness participation and perceptions of roles in advance care planning discussions with patients: a multi-site survey.

Author

Howard, Michelle, Langevin, Jessica, Bernard, Carrie, Tan, Amy, Klein, Doug, Slaven, Marissa, Barwich, Doris, Elston, Dawn, Arora, Neha, and Heyland, Daren K

Subjects
*MEDICAL personnel, *PRIMARY care, *MEDICAL protocols, *PATIENT surveys, *PARTICIPATION
Abstract

Background: People who engage in advance care planning (ACP) are more likely to receive health care that is concordant with their goals at the end of life. Little discussion of ACP occurs in primary care.Objective: The objective of this study was to describe primary care clinicians' perspectives on having ACP conversations with their patients.Methods: We conducted a survey of family physicians and non-physician clinicians in primary care in 2014-2015. We compared family physicians and non-physician clinicians on willingness, confidence, participation and acceptability for other clinicians to engage in six aspects of ACP (initiating, exchanging information, decision coaching, finalizing plans, helping communicate plans with family members and other health professionals) on scales from 0 = not at all/extremely unacceptable to 6 = very/all the time/extremely acceptable.Results: The response rate was 72% (n = 117) among family physicians and 69% (n = 64) among non-physician clinicians. Mean ratings (standard deviation [SD]) of willingness were high (4.5 [1.4] to 5.0 [1.2] for physicians; 3.4 [1.8] to 4.6 [1.6] non-physician clinicians). There was little participation (mean ratings 2.4 [1.7] to 2.7 [1.6] for physicians, 1.0 [1.5] to 1.4 [1.7] for non-physician clinicians). Non-physician clinicians rated confidence statistically significantly lower than physicians for all ACP aspects. Acceptability for non-physician clinician involvement was high in both groups (mean acceptability ratings greater than 4).Conclusion: Current engagement of primary care clinicians in ACP is low. Given the high willingness and acceptability for non-physician clinician involvement, increasing the capacity of non-physician clinicians could enable uptake of ACP in primary care. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

17. Demonstrating a Technology-Mediated Intervention to Support Medication Adherence in Community-Dwelling Older Adults in Primary Care: A Feasibility Study.

Author

Yu-Hin Siu, Henry, Delleman, Bethany, Langevin, Jessica, Mangin, Dee, Howard, Michelle, Qiyin Fang, Price, David, and Chan, David

Subjects
PATIENT compliance, PRIMARY care, OLDER people, FEASIBILITY studies, ADULTS
Abstract

Background: Medication non-adherence can lead to significant morbidity and mortality. This 4-week feasibility study aims to demonstrate that the eDosette intervention can be implemented with older adults in primary care. Method: Fifty-six older adults from four primary care sites in Southwestern Ontario, Canada participated. The intervention involved generating, for pharmacist review, weekly medication administration records based on transmitted data captured by the eDosette. The primary outcome is implementation feasibility defined by recruitment, adherence rates, frequency of captured missed and late doses, descriptions of clinical work resulting from the intervention, and participant feedback. Results: The recruitment rate was 24% (57/240); one withdrew due to personal reasons. The mean observed adherence rate was 82% (range 49%-100%). Overall, participants missed 505 and took 2,105 doses late; 118 clinical decisions occurred with 72 unique medication changes in 31 participants. Participants found the eDosette easy to use and did not feel that they were viewed negatively because of their potential non-adherence. Conclusion: The eDosette intervention could be feasibly implemented in primary care with older adults. Providing information about when an older adult takes their medications could play a role in medication adherence by prompting more informed discussions between the older adult and primary care clinicians. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

18. Additional file 6 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 6. PDF. Site fidelity to TAPER-RCT model. The checklist that will be used to measure a site’s adherence to the TAPER-RCT protocol.

19. Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 2. PDF. TIDier Checklist.

20. Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 2. PDF. TIDier Checklist.

21. Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 5. PDF. Data collection schedule. A diagram outlining the proposed timeline of the study.

22. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan L., Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O���Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-��ric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Background Polypharmacy in older adults can be associated with negative outcomes including falls, impaired cognition, reduced quality of life, and general and functional decline. It is not clear to what extent these are reversible if the number of medications is reduced. Primary care does not have a systematic approach for reducing inappropriate polypharmacy, and there are few, if any, approaches that account for the patient���s priorities and preferences. The primary objective of this study is to test the effect of TAPER (Team Approach to Polypharmacy Evaluation and Reduction), a structured operationalized clinical pathway focused on reducing inappropriate polypharmacy. TAPER integrates evidence tools for identifying potentially inappropriate medications, tapering, and monitoring guidance and explicit elicitation of patient priorities and preferences. We aim to determine the effect of TAPER on the number of medications (primary outcome) and health-related outcomes associated with polypharmacy in older adults. Methods We designed a multi-center randomized controlled trial, with the lead implementation site in Hamilton, Ontario. Older adults aged 70 years or older who are on five or more medications will be eligible to participate. A total of 360 participants will be recruited. Participants will be assigned to either the control or intervention arm. The intervention involves a comprehensive multidisciplinary medication review by pharmacists and physicians in partnership with patients. This review will be focused on reducing medication burden, with the assumption that this will reduce the risks and harms of polypharmacy. The control group is a wait list, and control patients will be given appointments for the TAPER intervention at a date after the final outcome assessment. All patients will be followed up and outcomes measured in both groups at baseline and 6 months. Discussion Our trial is unique in its design in that it aims to introduce an operationalized structured clinical pathway aimed to reduce polypharmacy in a primary care setting while at the same time recording patient���s goals and priorities for treatment. Trial registration Clinical Trials.gov NCT02942927. First registered on October 24, 2016.

23. Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, 3. Good health
Abstract

Additional file 3. PDF. TaperMD. A list of the questions on the TaperMD web-based platform.

24. Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 1. PDF. Spirit 2013 Checklist.

25. Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
fungi, 3. Good health
Abstract

Additional file 4. PDF. Quantitative patient outcomes measure descriptions. A list of the primary and secondary outcomes, descriptions of the measures and the psychometric properties of the measures.

26. Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
fungi, 3. Good health
Abstract

Additional file 4. PDF. Quantitative patient outcomes measure descriptions. A list of the primary and secondary outcomes, descriptions of the measures and the psychometric properties of the measures.

27. Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, 3. Good health
Abstract

Additional file 3. PDF. TaperMD. A list of the questions on the TaperMD web-based platform.

28. Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 5. PDF. Data collection schedule. A diagram outlining the proposed timeline of the study.

29. Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 1. PDF. Spirit 2013 Checklist.

Catalog

Books, media, physical & digital resources
See catalog results